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Abstract
The epidermis of the skin is a self-renewing, stratified epithelium that functions as the interface between the human body
and the outer environment, and acts as a barrier to water loss. Components of intercellular junctions, such as Claudins, are
critical to maintain tissue integrity and water retention. p63 is a transcription factor essential for proliferation of stem cells
and for stratification in epithelia, mutated in human hereditary syndromes characterized by ectodermal dysplasia. Both p63
and Claudin-1 null mice die within few hours from birth due to dehydration from severe skin abnormalities. These
observations suggested the possibility that these two genes might be linked in one regulatory pathway with p63 possibly
regulating Claudin-1 expression. Here we show that silencing of DNp63 in primary mouse keratinocytes results in a marked
down-regulation of Claudin-1 expression (280%). DNp63a binds in vivo to the Claudin-1 promoter and activates both the
endogenous Claudin-1 gene and a reporter vector containing a –1.4 Kb promoter fragment of the Claudin-1 gene.
Accordingly, Claudin-1 expression was absent in the skin of E15.5 p63 null mice and natural p63 mutant proteins, specifically
those found in Ankyloblepharon–Ectodermal dysplasia–Clefting (AEC) patients, were indeed altered in their capacity to
regulate Claudin-1 transcription. This correlates with deficient Claudin-1 expression in the epidermis of an AEC patient
carrying the I537T p63 mutation. Notably, AEC patients display skin fragility similar to what observed in the epidermis of
Claudin-1 and p63 null mice. These findings reinforce the hypothesis that these two genes might be linked in a common
regulatory pathway and that Claudin-1 may is an important p63 target gene involved in the pathogenesis of ectodermal
dysplasias.
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Introduction
To maintain homeostasis in multicellular organisms the
isolation and compartmentalization of the internal environment
is essential and is achieved by organization of ectodermal tissue in
multiple cellular sheets. Epithelial sheet architecture is dynamically
maintained through the combined action of tight junctions,
adherens junction and desmosomes. Of these, adherens junction
proteins, such as E-cadherin, and desmosomes are primarily
responsible for the adhesion between adjacent cells, whereas tight
junctions regulate permeability and the paracellular exchange of
water, ions, and macromolecules across epithelial sheets [1,2]. The
Tight Junction (TJ) family comprises three main classes of
proteins: claudins, occludin and junctional adhesion molecules.
Claudins and occludins build up the functional units responsible
for the tight sealing of the cells in epithelial sheets, whereas TJ
proteins, such as Tight Junction Protein 1 (TJP1), are responsible
for linking claudins and occludin to the actin cytoskeleton [3–5].
Claudins are directly involved not only in the formation of TJ
strands but also in their barrier function in simple epithelia.
Recent advances revealed that claudins are directly involved in
intercellular sealing of simple as well as stratified epithelia in
vertebrates.
Claudins expressing genes comprise a large family consisting of
at least 24 members in mice/humans [6–9]. When claudins are
expressed singly in fibroblasts lacking TJs, well-developed
networks of TJ strands are organized between adjacent transfec-
tants [10]. More than two claudin species are often co-expressed in
single cells of various tissues.
Recently, Claudin-1 (Cldn-1) null mice have been generated;
these mice show severe skin abnormalities and die of dehydration
within one day of birth. Although the layered organization of
keratinocytes appeared to be normal, the epidermal barrier was
severely affected in these mice [11].
The epithelium organization and the dehydration defects
observed in Cldn-1 null mice are similar to those observed in p63
null mice. Indeed, mice in which p63 was inactivated failed to
develop stratified epithelia and epithelial appendages, such as
teeth, hair follicles and mammary glands and died within one day
of birth from dehydration, as did the Cldn-1 null mice [12,13]. The
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Tp63 gene encodes a transcription factor homologous to the p53
tumor suppressor, which is consistently expressed in basal cells of
stratified epithelia [14]. Unlike p53, p63 does not function as a
classical tumor-suppressor; instead, it functions primarily in
epithelial-mesenchymal development during embryogenesis.
Multiple products are produced from the p63 gene. The use of
alternative promoters drives transcription of TAp63 proteins,
having an aminoterminal Trans Activation (TA) domain, a DNA
Binding (DB) domain and an Oligomerization Domain (OD), or
DNp63 proteins lacking the transactivation domain homologous to
that of p53 [15]. However, additional TA domains have been
identified that account for the transcriptional activities of the DN
isoforms [16–18]. In addition three alternative splicing routes at
the 39 end generate proteins with different C-termini, denoted a, b
and c. A Sterile Alpha Motif (SAM) is contained only in the a-
isoforms (TA and DN). The presence of a SAM, which is absent in
p53, is the most significant structural difference between p63 and
p53 [19]. SAM domains are protein-protein interaction domains
also found in other developmentally important proteins, such as
p73 and several Eph receptor tyrosine kinases [20].
Similarities between the Cldn-1 and p63 null mice suggested the
possibility that these two genes might be linked to the same
regulatory pathway or belong to a common signaling cascade with
p63 possibly regulating Cldn-1 expression.
Here we report that: 1) Cldn-1 expression is severely reduced
upon siRNA mediated downregulation of DNp63 isoforms, 2) Cldn-
1 expression is absent in the skin of E15.5 p63 null mice, 3) the
DNp63a isoform binds to the Cldn-1 promoter in keratinocytes in
vivo, 4) a 1.4 Kb Cldn-1 promoter fragment is activated by
DNp63a, 5) natural DNp63 mutations, in particular associated
with the AEC syndrome which displays the most severe skin
phenotype among p63 associated syndromes, were unable to
activate Cldn-1 transcription, and 6) a skin biopsy derived from an
AEC patient confirmed the in vitro evidences, with a clear and
sharp reduction of Cldn-1 expression in the basal layer of the
epidermis.
These results indicate that Cldn-1 is an important p63 target
gene needed for normal skin development and for the mainte-
nance of barrier function of the skin.
Materials and Methods
Plasmids
Expression vectors encoding all mouse p63 cDNAs in the
pcDNA3 expression vectors have been described [16]. The Cldn-1
promoters have also been previously described [21].
Cell cultures and transfection
Primary mouse keratinocytes were isolated from newborn mice
and cultured at 37uC in low calcium (0.05 mM CaCl2)
keratinocyte basal medium (KBM, Clonetics, San Diego, CA)
and EGF (10 ng/ml). Mouse primary keratinocytes were induced
to differentiate by CaCl2 (2 mM) treatment for 24 hours. Human
lung carcinoma H1299 cells stably transfected with a tet-on
DNp63a expression plasmid, were grown and induced with
Doxycyclin, as previously described [22].
The human osteosarcoma U2OS cell line was maintained in
Dulbecco’s modified Eagle’s medium (D-MEM) and 10% fetal calf
serum. For transfection, 50,000 cells were seeded into 24-well
multi-plates and on the next day transfected with Lipofectamine
2000 (Invitrogen) according to the manufacturer’s instructions.
The total amount of transfected DNA (1 mg) was kept constant
using empty vector when necessary. Twenty-four hours later, cells
were lysed and assayed for luciferase activity.
RNA interference and analysis
The scrambled- siRNA (Dharmacon Research) was used as
negative control. siRNA duplexes and targeting DNp63 and GFP
were obtained from MWG-Biotech (Ebersberg, Germany).
The sense strands of the siRNAs used in this study were as
follows:
-GFP (ctr) siRNA 59-GTTCAGCGTGTCCGGCGAG-39
-DNp63 siRNA 59-TGCCCAGACTCAATTTAGT-39
Primary mouse keratinocytes, plated on collagen-coated 35 mm
dishes were transfected with 0.5 mg siRNA/dish using Lipofecta-
mine 2000 (Invitrogen). 24 hours after transfection total mRNA
was extracted, subjected to retrotranscription and to RealTime
PCR using specific primers.
Semiquantitative RT-PCR and RealTime PCR
Total RNA was prepared from H1299 cells and from primary
mouse keratinocytes with TRIzol reagent (Sigma). 1 mg of total
RNA was retrotranscribed using Super Script II MMLV enzyme
(Invitrogen). RealTime PCR was performed on mouse primary
keratinocytes and on mouse ectoderm from Fore Limbs (FLs) and
Hind Limbs (HLs) as previously described [23].
The following oligonucleotides were used for gene amplifica-
tion:
Immunoblot analysis and antibodies
Twenty-four hours after transfection, cells were lysed in 100 ml
of loading buffer (2% sodium dodecyl sulfate, 30% glycerol,
300 mM b-mercaptoethanol, 100 mM Tris-HCl pH 6.8): extracts
were separated on SDS-10% polyacrylamide gels and transferred
to a nitrocellulose membrane (Scleicher & Schuell). The blots were
h-CLDN-1
Forward 59 ACTCCTTGCTGAATCTGAACAGT 39
Reverse 59 GGACACAAAGATTGCGATCAG 39
h-GAPDH
Forward 59 TCACCAGGGCTGCTTTTAAC 39
Reverse 59 TGGAAGATGGTGATGGGATT 39
m-CLDN-1
Forward 59 ACTCCTTGCTGAATCTGAACAGT 39
Reverse 59 GGACACAAAGATTGCGATCAG 39
m-CLDN-3
Forward 59 CTCATCGTGGTGTCCATCC 39
Reverse 59 ATGGTGATCTTGGCCTTGG 39
m-CLDN-10
Forward 59 AGCTTCTCTGCATCATTGG 39
Reverse 59 TTCTCCGCCTTGATACTTGG 39
m-GAPDH
Forward 59 TGTCAGCAATGCATCCTGCA 39
Reverse 59 TGTATGCAGGGATGATGTTC 39
m-CyclophilinA
Forward 59 ATGGTCAACCCCACCGTGTT 39
Reverse 59 CGTGTGAAGTCACCACCCT 39
m-Tp53
Forward 59 TCTACAAGAAGTCACAGCACATGAC 39
Reverse 59 CCTTCCACCCGGATAAGATGC 39
m-DNp63
Forward 59 ATGTTGTACCTGGAAAACAATG 39
Reverse 59 GATGGAGAGAGGGCATCAAA 39
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incubated with the Cldn-1 antibody (Zymed) or the 4A4 p63
antibody (Santa Cruz Biotech) and developed according to the
manufacturer’s instructions (Super Signal, Pierce).
Chromatin ImmunoPrecipitation (ChIP)
Mouse primary keratinocytes uninduced or induced to differ-
entiate for 24 hours were washed in PBS, incubated for
10 minutes with 1% formaldehyde and quenched with Glycine
0.1 M. Cells were sonicated and chromatin fragments of an
average length of 0.5 Kb recovered by centrifugation. Immuno-
precipitations were performed with ProtG-Sepharose (KPL, USA),
blocked twice at 4uC with 1 mg/ml salmon sperm DNA sheared at
500 bp length and 1 mg/ml BSA, for 2 hours and overnight.
Chromatin was precleared by adding ProtG-Sepharose for
2 hours at 4uC, aliquoted and incubated with 3–5 mg of p63
antibodies overnight at 4uC. DNA was released by incubating
samples for 5 hours at 65uC, phenol-extracted and ethanol
precipitated. Semiquantitative PCR was performed with the
following primers annealing to the mouse Cldn-1 regulatory region:
As control, oligonucleotides annealing to the Ikka mouse
promoter were used:
Preparation of tissue samples and in situ hybridization
Experiments involving the use of animals were approved by the
Institutional Animal Care Committee and by the Ministry of
Health. Pregnant females (p632/+6p632/+) [13] were sacrificed at
Embryonal day 15.5 (E15.5) of gestation, epidermal-dermal tissues
were dissected from the embryonic flank, fixed in PFA 4%,
cryoprotected in 20% sucrose, embedded in OCT and sectioned
at 11 mm. In situ hybridization was carried out with DIG-labeled
antisense RNA probes, according to published procedures [24].
The Claudin-1 probe (399 bp in length) corresponds to the coding
sequence and part of the 59 UTR of the murine mRNA. The p63
probe (497 bp in length) corresponds to exons 4-11 of murine p63
mRNA, common to both the TA and the DN transcripts.
Immunohistochemistry
Four-mm punch biopsy specimens were taken from normal skin
of healthy volunteers (n = 4). The declaration of Helsinki protocols
were followed and the patient parents gave written approved
consent before biopsy. A patient affected by AEC (I537T mutation
in p63) was subjected to skin biopsy on lesions after obtaining
informed consent from his parents. Paraffin embedded 5 mm skin
sections were kept at 60uC for 1 hour, and then incubated at 80uC
overnight in citrate buffer pH6 (DAKO Italia, Milan, Italy). The
sections were incubated for 1 hour at room temperature with the
appropriate dilution of anti-human Cldn-1 monoclonal antibody
(Zymed), anti-p63 (4A4, Santa Cruz Biotec) or control mouse
IGgs. Sections were stained with an avidin-biotin-peroxidase
technique (DAKOMilan, Italy) by using 3,39-diaminobenzidine as
a substrate (DAKO Milan, Italy).
Results
Cldn-1, 3 and 10 are downregulated in DNp63 deficient
keratynocites
Defects in the barrier function of the skin are evident in both
p63 null mice and in p63-dependent ectodermal dysplasias, such as
in the AEC syndrome. In order to determine the pattern of genes
controlled by p63 and involved in the control of skin development
and of barrier function, we have selectively downregulated DNp63
isoforms in primary mouse keratinocytes by means of specific
siRNAs (siDNp63) [25]. The expression of DNp63 upon siDNp63
was reduced by 80% while the expression of p53 did not change
(Figure 1A). As shown in Figure 1B, DNp63 downregulation caused
a strong decrease in the expression of Cldn-1 -3 and 10, identifyng
these genes as potential mediators of DNp63 control over barrier
function in adult skin.
Given the well known role played by Cldn-1 in the formation of
TJs, we decided to focus on its regulation by p63.
DNp63_a functionally interacts in vivo with two different
regions of the Cldn-1 gene
To study the potential role of p63 as a direct transcriptional
regulator of Cldn-1, we performed Chromatin Immuno Precipita-
tion (ChIP) experiments to verify its direct binding to the Cldn-1
promoter. To this aim, we used chromatin extracted from primary
mouse keratinocytes, endogenously expressing DNp63a, placed
under differentiating conditions by Ca2+ addition; chromatin was
immunoprecipitated with anti-p63 antibodies. We scanned the
Cldn-1 promoter with three pairs of primers; two of them were
designed on two regions of high homology between rat, mouse and
human promoters (Region 1 and Region 2, R1 and R2) while the
third one was designed on a region that did not show any
homology (Region 3, R3), as shown in Figure 2A. In Figure 2B,
the results showed that of the three amplicons used, the ones
corresponding to R1 and R2 of high homology between human,
mouse and rat, were positive for p63 binding.The R3 was negative
for p63 binding.
In order to verify whether or not the binding of DNp63a to the
endogenous Cldn-1 gene was associated to changes in Cldn-1 gene
expression, we used a cell line derived from the human H1299 cell
line, stably transfected with a Doxicycline inducible DNp63a [22];
this cell line was used to quantify the levels of Cldn-1 specific
R1- Forward 59 GGGATGCCTGATTCTCTTCA 39
R1- Reverse 59 TGGAAGTGAGAAGTGGCAGA 39
R2- Forward 59 TGGAAGCATCCCTTGTTTTC 39
R2- Reverse 59 TTGCTGTCCTCTCTGGGTCT 39
R3- Forward 59 CTGAACAGAGGCCATCCCTA 39
R3- Reverse 59 CACGTAGTCTGGCACACACA 39
Forward 59 CTCAAGTCGGAGAACAAGG 39
Reverse 59 CTCGAATCCTACCACACTCG 39
Figure 1. Cldn-1 expression is down-regulated upon siRNA to
DNp63. A) Primary mouse keratinocytes were transfected by control
siRNA (siGFP), scrambled siRNA (Dharmacon) or DNp63 specific siRNA
(siDNp63). 24 hours after transfection total RNA was extracted and
subjected to RealTime PCR to verify DNp63 and p53 downregulation.
Results are expressed as mean expression of three different samples.
Standard Deviations (SD) are indicated. B) Cldn-1, 3 and -10 expressions
in the same samples as in Figure 1A. Expression of the three genes was
normalized to CyclophilinA expression. SD from three different samples
is indicated.
doi:10.1371/journal.pone.0002715.g001
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transcript as well as Cldn-1 protein expression upon DNp63a
induction. To this aim total RNA and proteins were extracted and
used in semiquantitative RT-PCR reactions with oligonucleotides
specific for the Cldn-1 transcript and in western blot analysis with
anti Cldn-1 antibodies. Expression of endogenous Cldn-1 was
activated in response to DNp63a over-expression both at the
mRNA and protein levels (Figure 2C and 2D).
We have recently shown that the expression of the DNp63
isoforms increases during mouse limb development [23]: we
determined Cldn-1 expression in RNA samples extracted from
E10.5, E11.5 and E12.5 Hind Limb (HL) and Fore Limb (FL). As
shown in Figure 2E, there is a concomitant increase of DNp63 and
Cldn-1 expression at E12.5 in the HL (FL, data not shown).
Finally, we examined the expression of Cldn-1 in the skin of
E15.5 p63 null embryos [13], by in situ hybridization. Cldn-1
expression was detectable in the skin epithelium of p632/+
embryos, while absent in p632/2 ones (Figure 3A and B). As a
control for RNA preservation, consecutive sections were hybrid-
ized with a probe that detects both TA and DNp63 transcripts. In
fact, in the p632/2 mice, the p63 mRNA is still expressed from the
targeted allele, while no protein is being made [13]. p63
hybridization signal was detected in both normal and p63 null
skin, as expected (Figure 3C and D).
All together, these data indicate that p63 expression is necessary
for Cldn-1 expression in the skin epithelium and that upon
DNp63a expression, p63 is functionally associated in vivo to the
Cldn-1 gene and that this association enhances the transcription
from the Cldn-1 gene.
A 21.4 Kb fragment of the Cldn-1 promoter is regulated
by DNp63 isoforms
The results of the ChIP analysis prompted us to tackle a
functional analysis of the Cldn-1 promoter. To further study the
regulation of Cldn-1 expression by p63 we employed a luciferase
reporter plasmid containing a -1.4 Kb fragment of the rat Cldn-1
Figure 2. DNp63_a functionally interacts in vivo with the Cldn-1 gene. A) Schematic representation of the human, rat and mouse Cldn-1
promoter regions. Two regions of high interspecies homology were identified (R1 and R2, black and striped boxes respectively). The degree of
homology within R1 and R2 is shown on the right. R3, mapping at 23.5 Kb from the ATG of the Cldn-1 gene, did not show any homology and was
used as negative control. B) Three amplicons centered on R1, R2 and R3 of the Cldn-1 gene were used in semiquantitative PCR amplifications with
chromatin extracted from mouse primary keratinocytes, induced with Ca2+ for 24 hours, and immunoprecipitated with anti-p63 antibodies (4A4,
Santa Cruz Biotech). R1 and R2 were positives with the anti-p63 antibodies while R3 was negative. As positive control, oligonucleotides annealing to
the IKKa mouse promoter [25] were used. C) H1299 cells were treated with 20 mM Doxicycline in order to induce DNp63a expression. Thirty hours
after induction mRNA was extracted from uninduced (-Dox) and induced (+Dox) cells and levels of endogenous Cldn-1 and GAPDH were assessed by
semiquantitative RT-PCR. D) Expression of the Cldn-1 protein is clearly detected upon DNp63a expression in H1299 cells. E) RNA extracted from
mouse HL at E10.5, E11.5 and E12.5 (white, grey and black bars respectively) were used to verify DNp63 and Cldn-1 levels of expression.
doi:10.1371/journal.pone.0002715.g002
Figure 3. Reduced Cldn-1 expression in the skin epithelium of
p63 null embryos. Sections through the skin epithelium and dermis of
p632/+(A and C) and p632/2 (B and D) embryos, hybridized with Cldn-1
(A and B) and with p63 (A and B) probes. Black arrows, hybridization
signal on epithelial cells. Black asterisks in B, absence of signal. Scale bar
(D, bottom right), 10 mm.
doi:10.1371/journal.pone.0002715.g003
p63 Activates Claudin-1 Gene
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regulatory region [21], that contains both conserved R1 and R2
(Figure 2A). This fragment contains also two putative p53 binding
sites which location however did not overlap with R1 and R2
(Figure 4A). We performed transient transfections in the U2OS
cell line that do not express p63 and express p53; we systematically
co-transfected different doses of plasmids encoding all p63
isoforms with the 21.4 Kb Cldn-1 promoter in subsequent
experiments. As shown in Figure 4B, in the U2OS cells the
Cldn-1 promoter activity was repressed by the co-transfection of
serial doses of TAp63b and TAp63c expression plasmids while
TAp63a was inactive. On the other hand, co-transfection of the
DNp63a isoform transactivated this promoter while DNp63b and
DNp63c isoforms had little effect on this promoter. p53
transfection repressed the activity on the Cldn-1 promoter. We
repeated the same experiments in the Saos-2 cell line, expressing
no p53 and no p63 endogenously, and obtained similar results
(data not shown).
In order to identify the region of the Cldn-1 promoter
responsible for the observed regulation by DNp63a, we employed
serial deletion constructs of the Cldn-1 promoter [21] in co-
transfection experiments with the DNp63a isoform in the U2OS
cells. The results (Figure 4C) clearly showed that deletion of a
region encompassing 21.4 kb and 2613 bp of the Cldn-1
promoter, deleting R2 and one of the two putative p53 binding
sites, resulted in a reduction of transactivation by DNp63a and a
further deletion up to 2226 bp retained a similar activity to the
2613 construct. Strinkingly, a deletion up to 261 bp, shown to be
necessary and sufficient for Cldn-1 expression in rat epididymal
cells [21], showed high transactivation by DNp63a. Within these
61 bp, the R1 is contained; two Sp1 binding sites have been
identified, exactly within R1, and mutation of the distal Sp1 site
resulted in a 4 fold reduction of Cldn-1 basal activity [21]. Since
p63 has been shown to physically and functionally interact with
Sp1 [26,27], we employed a version of the Cldn-1 promoter
mutated in the Sp1 distal site in co-transfection with DNp63a:
mutation of the distal Sp1 binding site reduced DNp63a dependent
transactivation of the Cldn-1 promoter, suggesting that indeed the
activation observed in the 261 bp fragment could be the result of
p63 interacting with Sp1 (Figure 4D).
These data indicate that the DNp63a isoform is the main inducer
of the Cldn-1 promoter and that two regions in the Cldn-1 promoter
are mediating this activity: the first one contained within 21.4 kb
and 2613 bp where the R2 of high interspecies homology is
contained and where p63 binds in ChIP experiments; the second
one, where p63 also binds, containing the R1 and two Sp1 binding
sites; the distal Sp1 binding sites seems to mediate part of p63 action.
The AEC natural p63 are loss of function mutation for
Cldn-1 promoter activity
The phenotypic similarity between the Cldn-1 and p63 null
mice, and the phenotype of patients affected by syndromes
associated with p63 mutations, prompted us to analyze the
possibility that natural p63 mutations (specifically those associated
with ectodermal defects in human) affect the transcriptional
function of p63 on the Cldn-1 promoter. We used p63 mutations
associated to two human syndromes, AEC and Split Hand Foot
Malformation type IV (SHFM-IV): in AEC patients severe skin
abnormalities are observed that are absent in SHFM-IV patients.
Figure 4. The Cldn-1 promoter is regulated by the DNp63_ isoforms. A) Schematic representation of the Cldn-1 promoter constructs used.
White boxes: Sp1 binding sites. Black boxes: p53 binding sites. B) U2OS cells were transfected with the 21.4 Kb Cldn-1 reporter plasmid (0.3 mg)
(white bar). Different quantities of expression plasmids for the p63 isoforms and p53 were cotransfected (0.025, 0.05 and 0.1 mg) (striped, light grey
and black bars respectively). C) U2OS cells were transfected with the deletion constructs of the Cldn-1 reporter plasmid (0.3 mg). Different quantities
of expression plasmids for the DNp63a were cotransfected (0.025, 0.05 and 0.1 mg) (striped, light grey and black bars respectively). D) U2OS cells
were transfected with the wild- type or the mutated 261 bp promoter constructs (0.3 mg). Different quantities of expression plasmids for the
DNp63a were cotransfected (0.025, 0.05 and 0.1 mg) (striped, light grey and black bars respectively). Cells were lysed after 24 hours and luciferase
activity was determined. The basal activity of the reporter plasmids was set to 1. Data are presented as fold activation/repression relative to the
sample without effectors. Each bar of the histogram represents the mean of three independent transfection duplicates. Standard deviations are
indicated.
doi:10.1371/journal.pone.0002715.g004
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Co-transfection experiments in the U2OS cell line, clearly showed
that the TA-AEC518 and TA-AEC540 mutants had gained
activation potential compared to the TA-SHFM639 mutant and
wild type TAp63a that did not possess this activity (Figure 5A). On
the other hand, DN-AEC518 and DN-AEC540 mutants had a
reduced transactivation potential while the activation potential of
the DN-SHFM639 mutant was very similar to that of wild type
DNp63a (Figure 5B).
In patients, p63 mutations are always occurring as dominant
heterozygous mutations. In order to mimic the heterozygous state
found in patients in vivo, we performed co-transfection experiments
of TAp63a with TA-AEC518 and DNp63a with DN-AEC518 (1:1
ratio). As shown in Figure 5C, co-transfection of TAp63a with
TA-AEC518 resulted in incresead levels of transactivation
compared to that obtained TAp63a alone. On the other hand,
co-transfection of DN-AEC518 with DNp63a reduced the
transactivation obtained with DNp63a alone (Figure 5D).
These data show that Cldn-1 expression is profoundly affected
by p63 mutations associated to the AEC syndrome and raises the
possibility that Cldn-1 expression may also be altered in the skin
epithelium of AEC patients.
Reduced expression of Cldn-1 in AEC skin
Based on the data presented thus far, we hypothesize that Cldn-
1 may be involved in the pathogenesis of skin defects observed in
AEC syndrome. To verify this hypothesis in vivo we examined
Cldn-1 expression in skin lesions of a patient with a severe form of
AEC syndrome associated to the presence of the I537T mutation
in one of the p63 allele (A. Costanzo, unpublished data), a
mutation already described in other cases of AEC cases [19].
We carried out show immunohistochemical staining to detect p63
and Cldn-1 expression in normal skin compared to AEC lesional skin.
While p63 expression was equally distributed in both the normal and
the AEC skin (Figure 6, panels A–B), we observed a profound change
in Cldn-1 expression pattern in the AEC skin. In normal skin Cldn-1
was strongly expressed on the membrane of keratinocytes throughout
the epidermis layers, while in the AEC epidermis we were unable to
detect Cldn-1 expression in the basal and suprabasal layers and
observed only a weak positivity on the membrane of few cells of the
granular layer (Figure 6, compare panels C–D). Thus, Cldn-1 is
strongly down-regulated in the AEC skin; this observation suggests
that Cldn-1 may belong to the set of p63 target genes whose
modification causes skin fragility in AEC patients.
Discussion
The skin is a self-renewing, stratified epithelium that functions
as the interface between the human body and the outer
environment. The epidermal layer not only protects us from
environmental pathogens but also acts as a ‘barrier’ to water loss.
The molecules regulating this important function are components
of intercellular junctions, termed TJ, which play an essential role
in development of barrier function in the skin.
Data derived from the analysis of TJ structure and null mice
phenotype indicate that Cldn-1 is required for TJ barrier function to
prevent water loss [11]. Defects in skin barrier function are present in
several skin diseases including inflammatory and genetic diseases.
Figure 5. The AEC mutations subvert p63 transcriptional potential. A) U2OS cells were transfected with the21.4 Kb Cldn-1 reporter plasmid
(0.3 mg) (white bar). Different quantities of expression plasmids for TAp63 mutants were cotransfected (0.025, 0.05, 0.1 mg) (striped, light grey and
dark grey bars respectively). B) U2OS cells were transfected with the 21.4 Kb Cldn-1 reporter plasmid (0.3 mg) (white bar). Different quantities of
expression plasmids for DNp63 mutants were cotransfected (0.025, 0.05, 0.1 mg) (striped, light grey and dark grey bars respectively). C) 0.05 mg of
TAp63a or TA-AEC518 were transfected either alone or together in order to reproduce the heterozygous state found in AEC patients. D) 0.05 mg of
DNp63a or DN-AEC518 were transfected either alone or together in order to reproduce the heterozygous state found in AEC patients. Cells were
lysed after 24 hours and luciferase activity was determined. The basal activity of the reporter plasmids was set to 1. Data are presented as fold
activation/repression relative to the sample without effectors. Each bar of the histogram represents the mean of three independent transfection
duplicates. Standard deviations are indicated.
doi:10.1371/journal.pone.0002715.g005
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We have found that Cldn-1, the principal component of TJs, is
a downstream target of the p63 transcription factor, essential for
proper epidermal development.
p63 controls several aspects of stratified epithelia development
and homeostasis acting through the transcriptional regulation of a
definite set of genes which contribute to proliferation, differenti-
ation and cell-cell adhesion in stratified epithelia [28]. Loss of p63
expression in null mice leads to death within 24 hours after birth
because of massive water loss, suggesting that the TJs function is
lost in the skin of these mice.
Our data indicate that the DNp63a isoform, which is expressed
in ectodermal cells concomitantly with the activation of the
stratification program in mouse embryo and throughout adult
stratified epithelia, is a direct transcriptional activator of Cldn-1.
Cldn-1 activation by p63 seems to be isoform specific, being
DNp63a the best activator and TAp63 isoforms mild repressors.
DNp63a seems to play a major role in regulating expression of the
Cldns family; infact, we have observed down regulation of Cldn-1,
Cldn-3 and Cldn-10 in cells transfected with siRNA targeting
DNp63 and Cldn-1 was undetectable in the skin of p63 null mice,
further supporting the evidences that Cldn-1 expression is
dependent on p63 expression.
A complex regulation has been shown to occur for the Cldns.
Studies on compensatory responses of different Cldns appear to be
tissue specific. Studies in MDCK cells using siRNA failed to show
any compensatory regulatory mechanisms following the down
regulation of Cldns 2-4 and Cldn-7 [29]. Others have reported
that overexpression of Cldn-2, -7, -15 did not alter the expression
of other Cldns in Caco cells [30–32]. In contrast, Cldn-12
overexpression in Caco cells resulted in an increased expression of
Cldn-2. Yu et al. have also reported that overexpression of Cldn-8
results in the downregulation of Cldn-2 [33]. Gow et al. reported
increased expression of Cldn-3 in basal cells of the cochlea of Cldn-
1 null mice, however, other Cldns were unaffected [34].
Using bioinformatic analysis, we identified two regions (R1 and
R2) of high sequence homology between the rat, mouse and
human Cldn-1 promoter regions. Both R1 and R2 are bound by
DNp63a in keratinocytes induced to differentiate. The observation
of DNp63 recruitment on Cldn-1 promoter upon keratinocyte
differentiation suggests that Cldn-1 may be part of an important set
of genes, such as IKKa [25], which are specifically activated by
DNp63 and required for induction of correct stratification
program. Moreover, both R1 and R2 are necessary to achieve
the full activation by DNp63, as determined by luciferase
transcriptional assays (Fig. 4C).
In the Cldn-1 promoter the bioinformatics analysis identified two
p53 binding sites; these two sites did not however overlap with R1
and R2 and p53 had a repressive effect on Cldn-1 promoter
activity. The first p53 binding site, located at 21.2 Kb of the Cldn-
1 promoter, is quite close to the R2 region (Figure 4A) and, due to
the average size of the chromatin used in the ChIP analysis, we
cannot exclude that p63 is indeed binding to this site. The second
p53 binding site, located at 20.5 Kb, doesn’t seems to play a role
in DNp63a mediated transactivation since its deletion did not have
any effect on DNp63a mediated transactivation of the Cldn-1
promoter (compare the 2613 bp and 2226 bp constructs,
Figure 4C).
The 261 bp construct showed very high levels of transactiva-
tion by DNp63a; this can be explained by the deletion of the2125
to 261 region that has been shown to repress Cldn-1 promoter
activity [21]. The R1 is contained within the 261 bp construct
where two Sp1 binding sites have been identified [21]. Sp1 binding
to the distal Sp1 site has been shown to be important for basal
activity of the Cldn-1 promoter in epididymal cells [21]. p63, as
p53, can bind DNA directly or can interact with other
transcription factors already bound to the DNA. p63 has been
shown to physically and functionally interact with components of
the basal transcriptional apparatus such as NF-Y [35] and Sp1
[26,27]. Mutation of the Sp1 distal site in the Cldn-1 promoter
reduced DNp63a dependent transactivation, suggesting that the
observed activation by DNp63a on the -61 bp Cldn-1 promoter
construct could be the result of p63 interacting with Sp1. A finer
analysis of the Cldn-1 promoter will help to clarify these points.
Dominant mutations in the p63 gene cause a specific subset of
syndromes characterized by various degrees of skin/hair defects
and by other phenotypes including craniofacial and limb
malformations, whose cellular basis is not fully understood.
Among these, the AEC syndrome is characterized by severe skin
defects at birth with inflammation, epidermal fragility and
decreased skin barrier function [36]. We have found that
DNp63 mutants carrying natural mutations found in AEC
syndrome patients cannot activate Cldn-1 expression anymore
and act as dominant negative molecules towards the wild type
DNp63a isoform. This latter observation is in agreement with the
heterozygous nature of AEC syndrome [37–39]. On the contrary,
DNp63 mutants derived from SHFM-IV syndrome, which is not
associated to skin fragility, do not display any defect in the
activation of Cldn1 reporter gene, indicating Cldn-1 as an AEC
specific p63 target gene. To verify this hypothesis we have
analyzed Cldn-1 expression by immunohistochemistry in the
lesional skin of a patient affected by AEC syndrome, who was
genotyped as having the I537T mutation in the SAM domain of
p63. We have observed a strong downregulation of Cldn-1 levels
in basal and suprabasal layers of AEC epidermis as compared to
normal human skin. p63 expression was not affected, further
reinforcing the concept of dominant negative nature of AEC
mutations.
Taken together our data indicate Cldn-1 as transcriptional target
of the disease gene p63, potentially involved in the pathogenesis of
the skin dysplasia observed in AEC patients.
Figure 6. The I537T AEC mutation alter Cldn-1 expression in
vivo. Skin sections from healthy donor (A and C) and from lesional skin
of a patient affected by AEC syndrome (I537T mutation in the SAM
domain of p63) (B and D) were subjected to immunohistochemistry
with specific antibodies to reveal the pattern of expression of p63 (A
and B) and Cldn-1 (C and D). Black arrows, immunohistochemistry
signal on epithelial cells. Black asterisks in D, absence of signal. Black
bars indicate 10 mm.
doi:10.1371/journal.pone.0002715.g006
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